TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ENTX

Entera Bio Ltd

Healthcare · Biotechnology

2.70$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Entera Bio Ltd (ENTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -7.4 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ENTX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.5 -3.1 -4.5 -9.8 -8.9 -11 -9.1 -12 -7.3 -6.8 -7.4
0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0
0.4 1.5 4.9 1.2 1.5 0.9 1.9 2.2 1.7 2.6 2.8
0.9 -2.7 4.6 0.7 0.8 -0.3 1.7 2.3 – – –
-0.2 0.4 0.9 -0.5 0.7 -0.4 1.4 -1.8 -0.2 0.1 1.3
0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1
-0.1 -1.1 1.0 -4.1 3.9 -0.1 0.0 -0.1 0.0 0.0 -0.1
2.5 – 12 9.6 13 – – – – – –
2.0 7.2 -1.0 -0.1 -0.1 -0.1 – – – – –
4.5 7.2 11 9.6 13 4.1 25 0.0 6.0 4.5 14
0.9 3.0 7.6 -4.2 7.7 -6.6 16 -13 -1.3 -2.3 6.2
-3.5 -3.2 -4.6 -9.9 -9.0 -11 -9.1 -13 -7.3 -6.8 -7.5

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?